Latest Insider Transactions at Replimune Group, Inc. (REPL)
This section provides a real-time view of insider transactions for Replimune Group, Inc. (REPL). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Replimune Group, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Replimune Group, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 02
2021
|
Robert Coffin Director |
SELL
Open market or private sale
|
Direct |
7,810
-0.44%
|
$312,400
$40.04 P/Share
|
|
Jun 29
2021
|
Robert Coffin Director |
SELL
Open market or private sale
|
Direct |
22,826
-1.26%
|
$913,040
$40.05 P/Share
|
|
Jun 28
2021
|
Robert Coffin Director |
SELL
Open market or private sale
|
Direct |
14,663
-0.81%
|
$586,520
$40.04 P/Share
|
|
Jun 15
2021
|
Colin Love Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
30,000
-1.69%
|
$1,020,000
$34.16 P/Share
|
|
May 10
2021
|
Tanya Lewis Chief Dev. Op. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
73,333
+50.0%
|
-
|
|
May 03
2021
|
Sushil Patel Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
88,333
+50.0%
|
-
|
|
Apr 15
2021
|
Colin Love Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
30,000
-1.62%
|
$900,000
$30.34 P/Share
|
|
Apr 01
2021
|
Colin Love Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
39,285
+4.07%
|
-
|
|
Apr 01
2021
|
Philip Astley Sparke Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
85,415
+5.99%
|
-
|
|
Apr 01
2021
|
Robert Coffin Director |
BUY
Grant, award, or other acquisition
|
Direct |
76,865
+4.05%
|
-
|
|
Apr 01
2021
|
Jean M. Franchi Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
46,035
+50.0%
|
-
|
|
Apr 01
2021
|
Andrea Pirzkall Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,500
+48.81%
|
-
|
|
Apr 01
2021
|
Pamela Esposito Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
34,165
+13.98%
|
-
|
|
Mar 15
2021
|
Colin Love Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
30,000
-1.1%
|
$990,000
$33.32 P/Share
|
|
Feb 16
2021
|
Colin Love Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
30,000
-1.6%
|
$1,080,000
$36.23 P/Share
|
|
Feb 08
2021
|
Omega Fund Iv, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
5,249
-0.1%
|
$236,205
$45.0 P/Share
|
|
Jan 26
2021
|
Omega Fund Iv, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
30,350
-0.29%
|
$1,365,750
$45.69 P/Share
|
|
Jan 26
2021
|
Jason P Rhodes Director |
SELL
Open market or private sale
|
Indirect |
5,558
-0.58%
|
$255,668
$46.14 P/Share
|
|
Jan 22
2021
|
Omega Fund Iv, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
11,359
-0.11%
|
$511,155
$45.04 P/Share
|
|
Jan 22
2021
|
Robert Coffin Director |
SELL
Open market or private sale
|
Direct |
60,000
-1.68%
|
$2,640,000
$44.43 P/Share
|
|
Jan 19
2021
|
Pamela Esposito Chief Business Officer |
SELL
Open market or private sale
|
Direct |
5,727
-1.58%
|
$240,534
$42.81 P/Share
|
|
Jan 19
2021
|
Pamela Esposito Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,727
+3.06%
|
$5,727
$1.01 P/Share
|
|
Jan 19
2021
|
Philip Astley Sparke Executive Chairman |
SELL
Open market or private sale
|
Direct |
8,432
-0.33%
|
$354,144
$42.78 P/Share
|
|
Jan 19
2021
|
Colin Love Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
7,857
-0.41%
|
$329,994
$42.82 P/Share
|
|
Jan 15
2021
|
Omega Fund Iv, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
1,916
-0.04%
|
$86,220
$45.19 P/Share
|
|
Jan 15
2021
|
Pamela Esposito Chief Business Officer |
SELL
Open market or private sale
|
Direct |
29,273
-14.26%
|
$1,258,739
$43.58 P/Share
|
|
Jan 15
2021
|
Pamela Esposito Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
29,273
+12.48%
|
$29,273
$1.01 P/Share
|
|
Jan 15
2021
|
Philip Astley Sparke Executive Chairman |
SELL
Open market or private sale
|
Direct |
16,568
-0.43%
|
$712,424
$43.89 P/Share
|
|
Jan 15
2021
|
Colin Love Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
22,143
-0.76%
|
$952,149
$43.96 P/Share
|
|
Jan 14
2021
|
Omega Fund Iv, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
17,664
-0.33%
|
$794,880
$45.09 P/Share
|
|
Jan 14
2021
|
Pamela Esposito Chief Business Officer |
SELL
Open market or private sale
|
Direct |
20,000
-10.2%
|
$900,000
$45.02 P/Share
|
|
Jan 14
2021
|
Pamela Esposito Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+9.26%
|
$20,000
$1.01 P/Share
|
|
Jan 14
2021
|
Philip Astley Sparke Executive Chairman |
SELL
Open market or private sale
|
Direct |
25,000
-0.64%
|
$1,075,000
$43.82 P/Share
|
|
Jan 14
2021
|
Jean M. Franchi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
14,900
-97.99%
|
$655,600
$44.28 P/Share
|
|
Jan 14
2021
|
Jean M. Franchi Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,900
+50.0%
|
$208,600
$14.08 P/Share
|
|
Jan 13
2021
|
Jean M. Franchi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
100
-100.0%
|
$4,400
$44.19 P/Share
|
|
Jan 13
2021
|
Jean M. Franchi Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
100
+50.0%
|
$1,400
$14.08 P/Share
|
|
Dec 23
2020
|
Pamela Esposito Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,704
+22.37%
|
$50,704
$1.75 P/Share
|
|
Dec 22
2020
|
Robert Coffin Director |
SELL
Open market or private sale
|
Direct |
220,000
-10.87%
|
$8,800,000
$40.04 P/Share
|
|
Dec 18
2020
|
Jason P Rhodes Director |
SELL
Open market or private sale
|
Indirect |
4,319
-0.53%
|
$177,079
$41.95 P/Share
|
|
Dec 17
2020
|
Jason P Rhodes Director |
SELL
Open market or private sale
|
Indirect |
11,535
-1.36%
|
$484,470
$42.0 P/Share
|
|
Dec 16
2020
|
Jason P Rhodes Director |
SELL
Open market or private sale
|
Indirect |
12,675
-1.45%
|
$532,350
$42.13 P/Share
|
|
Dec 15
2020
|
Jason P Rhodes Director |
SELL
Open market or private sale
|
Indirect |
40,819
-1.42%
|
$1,755,217
$43.2 P/Share
|
|
Dec 14
2020
|
Jean M. Franchi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
25,000
-88.66%
|
$1,050,000
$42.88 P/Share
|
|
Dec 14
2020
|
Jean M. Franchi Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+50.0%
|
$350,000
$14.08 P/Share
|
|
Dec 14
2020
|
Jason P Rhodes Director |
SELL
Open market or private sale
|
Indirect |
37,659
-1.22%
|
$1,619,337
$43.43 P/Share
|
|
Dec 11
2020
|
Pamela Esposito Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,590
+9.13%
|
$37,770
$3.3 P/Share
|
|
Dec 11
2020
|
Jason P Rhodes Director |
SELL
Open market or private sale
|
Indirect |
31,636
-1.45%
|
$1,360,348
$43.62 P/Share
|
|
Dec 10
2020
|
Jason P Rhodes Director |
SELL
Open market or private sale
|
Indirect |
34,391
-1.0%
|
$1,478,813
$43.5 P/Share
|
|
Dec 10
2020
|
Philip Astley Sparke Executive Chairman |
SELL
Open market or private sale
|
Direct |
25,000
-0.63%
|
$1,075,000
$43.03 P/Share
|